Updated 2026
Able C, Liao B, Saffati G, et al
It is how to use the 12 to 24 months before a potential 2026 approval productively, both in terms of metabolic health optimization and in terms of positioning to access retatrutide as quickly as possible once it is approved
It was a pre-approval cardiac safety assessment trial with a primary objective of non-inferiority to placebo, which was basically done to get early approval as per regulatory guidance
But the face you see a year after surgery isnt guaranteed to be the face you have at year five if your weight changes a lot
Back Unger, RH, Ketterer, H Dupr, J, Eisentraut, I (1967) 'The effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anesthetized dogs', Journal Clinical Investigation , 46/4, 63045